Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

7.35
Delayed Data
As of Sep 23
 +0.10 / +1.38%
Today’s Change
4.15
Today|||52-Week Range
9.85
-8.92%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close7.25
Today’s open7.26
Day’s range7.06 - 7.35
Volume31,243
Average volume (3 months)56,861
Market cap$94.7M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)-1.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+21.34%
P/E ratioNM
Price/Sales11.71
Price/Book95.92

Competitors

 Today’s
change
Today’s
% change
CFRXContraFect Corp+0.14+6.42%
FATEFate Therapeutics In...-0.10-2.82%
AUPHAurinia Pharmaceutic...+0.12+5.15%
ONSOncobiologics Inc+0.01+0.22%
Data as of 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$7.2M
Annual profit (last year)-$18.0M
Net profit margin-250.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Adam S. Grossman
Chief Financial &
Principal Accounting Officer, VP
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

Search for Jobs